Co-ordinate induction of collagen type I and biglycan expression in keloids

British Journal of Dermatology

Volumn 135, Issue 3, 1996, Pages 394-399

  Hunzelmann, N ^a   Anders, S ^a   Sollberg, S ^a   Schonherr E ^b   Krieg, T ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIGLYCAN; COLLAGEN TYPE 1; MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KELOID; PRIORITY JOURNAL;

EID: 0029819947     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb01502.x     Document Type: Article

References (26)

1. Fisher LW, Termine JD, Young MF. Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several non connective tissue proteins in a variety of species. J Biol Chem 1989; 264: 4571-6.
2. Krusius T, Ruoslahti E. Primary structure of extracellular matrix proteoglycan core protein deduced from cloned cDNA. Proc Natl Acad Sci USA 1986; 83: 7683-7.
3. Hardingham TE, Fosang AJ. Proteoglycans: many forms and many functions. FASEB J 1992, 6: 861-70.
4. Bianco P, Fisher LW, Young MF et al. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. J Histochem Cytochem 1990; 38: 1549-63.
5. Scott JE, Haigh M. Identification of specific binding sites for keratan sulphate proteoglycans and chondroitin-dermatan sulphate proteoglycans on collagen fibrils in cornea by the use of Cupromeronic Blue in critical-electrolyte-concentration techniques. Biochem J 1988; 253: 607-10.
6. Vogel K, Paulsson M, Heinegard D. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. Biochem J 1984; 223: 587-97.
7. Fleischmajer R, Fisher LW, MacDonald ED et al. Decorin interacts with fibrillar collagen of embryonic and adult human skin. J Struct Biol 1991; 106: 82-90.
8. Schönherr E, Witsch-Prehm P, Harrach B et al. Interaction of biglycan with type I collagen. J Biol Chem 1995; 270: 2776-83.
9. Miosge N, Flachsbart K, Goetz W et al. Light and electron microspical immunohistochemical localization of the small proteoglycan core proteins decorin and biglycan in human knee joint cartilage. Histochemical J 1994; 26: 939-45.
10. Bidanset DJ, LeBaron R, Rosenberg L et al. Regulation of cell substrate adhesion: effects of small galactosaminoglycan-containing proteoglycans. J Cell Biol 1992; 118: 1523-31.
11. Ruoslahti E, Yamaguchi Y. Proteoglycans as modulators of growth factor activities. Cell 1991; 64: 867-9.
12. Murray JC, Pollack SV, Pinnell SR. Keloids: a review. J Am Acad Dermatol 1981; 4: 461-70.
13. Peltonen J, Hsiao LL, Jaakola S et al. Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor beta 1 mRNA. J Invest Dermatol 1991; 97: 240-8.
14. Schaumberg-Lever G. The alkaline phosphatase anti-alkaline phosphatase technique in dermatopathology. J Cutan Pathol 1987; 14: 6-9.
15. Hunzelmann N, Schönherr E, Bonnekoh B et al. Altered immunohistochemical expression of small proteoglycans in the tumor tissue and stroma of basal cell carcinoma. J Invest Dermatol 1995; 104: 509-13.
16. Maniatis T, Frisch EF, Sambrook J. Molecular Cloning, New York: Cold Spring Harbor Laboratory, 1982; pp 187-207.
17. Chu ML, Myers JC, Bernard MP et al. Cloning and characterization of live overlapping cDNAs specific for the human α1 (I) collagen chain. Nucleic Acids Res 1982; 10: 5925-34.
18. Steiljen PM, Maessen E, Kresse H et al. Expression of tenascin, biglycan and decorin in disorders of keratinization. Br J Dermatol 1994; 130: 564-8.
19. Järveläinen HT, Kinsella MG, Wight TN, Sandell LJ. Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J Biol Chem 1991; 266: 23274-81.
20. Kähäri VM, Larjava H, Uitto J. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. J Biol Chem 1991; 266: 10608-15.
21. Adany R, Heimer R, Caterson B et al. Altered expression of chondroitin sulfate proteoglycan in the stroma of human colon carcinoma. J Biol Chem 1990; 265: 11389-96.
22. Iozzo RV. Proteoglycans and neoplasia. Cancer Metastasis Rev 1988; 7: 39-50.
23. Westergren-Thorsson G, Hernnas J, Särnstrand B et al. Altered expression of small proteoglycans, collagen and transforming growth factor-β in developing bleomycin-induced pulmonary fibrosis in rats. J Clin Invest 1993; 92: 632-7.
24. Varga J, Rosenbloom J, Jimenez SA. Transforming growth factor-β causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblasts. Biochem J 1987; 247: 597-604.
25. Tan EM, Hoffren J, Rouda S et al. Decorin, versican, and biglycan gene expression by keloid and normal dermal fibroblasts: differential regulation by basic fibroblast growth factor. Exp Cell Res 1993; 209: 200-7.
26. Shetlar MR, Shetlar CL, Linares HA. The hypertrophic scar: location of glycosaminoglycans within scars. Burns 1977; 4: 14-19.